AAAAAA
Results:
1-12
|
Results: 12
Authors:
EELES R
SIMARD J
EDWARDS S
TEARE D
DUROCHER F
EASTON D
DEARNALEY D
SHEARER R
ARDERNJONES A
DOWE A
BADZIOCH M
AMOS C
NAROD S
FOULKES W
Citation: R. Eeles et al., DOES THE HEREDITARY PROSTATE-CANCER GENE, HPC1 CONTRIBUTE TO A LARGE PROPORTION OF FAMILIAL PROSTATE-CANCER - RESULTS FROM THE CRC BPG UK, TEXAN AND CANADIAN CONSORTIUM/, European journal of human genetics, 6, 1998, pp. 4003-4003
Authors:
MCCREADY R
TRELEAVEN J
ALDEEN A
DEARNALEY D
POWLES R
Citation: R. Mccready et al., PBSC TRANSPLANTATION IN PATIENTS RECEIVING ABLATIVE DOSES OF RE-186 HEDP FOR SKELETAL SECONDARIES FROM PROSTATE-CANCER, Bone marrow transplantation, 21, 1998, pp. 795-795
Authors:
HORWICH A
HUDDART R
DEARNALEY D
Citation: A. Horwich et al., MARKERS AND MANAGEMENT OF GERM-CELL TUMORS OF THE TESTES, Lancet, 352(9139), 1998, pp. 1535-1538
Authors:
WILSON J
KHOO V
MEYER L
BIDMEAD M
WARRINGTON J
HELYER S
GADD J
HUDDART R
HORWICH A
DEARNALEY D
Citation: J. Wilson et al., RANDOMIZED TRIAL OF HIGH-DOSE CONFORMAL RADIOTHERAPY FOR PROSTATE-CANCER - INITIAL REPORT OF ACUTE TOXICITY, British Journal of Cancer, 78, 1998, pp. 21-21
Authors:
WILSON J
KHOO V
BIDMEAD M
AIRD E
MAYLES P
DEARNALEY D
Citation: J. Wilson et al., QUALITY ASSURANCE OF TARGET DEFINITION IN THE MRC RT-01 TRIAL OF HIGH-DOSE CONFORMAL RADIOTHERAPY (CRT) IN PROSTATE-CANCER, British Journal of Cancer, 78, 1998, pp. 22-22
Authors:
EELES RA
DUROCHER F
EDWARDS S
TEARE D
BADZIOCH M
HAMOUDI R
GILL S
BIGGS P
DEARNALEY D
ARDERNJONES A
DOWE A
SHEARER R
MCLENNAN DL
NORMAN RL
GHADIRIAN P
APRIKIAN A
FORD D
AMOS C
KING TM
LABRIE F
SIMARD J
NAROD SA
EASTON D
FOULKES WD
FOULKES WD
Citation: Ra. Eeles et al., LINKAGE ANALYSIS OF CHROMOSOME 1Q MARKERS IN 136 PROSTATE-CANCER FAMILIES, American journal of human genetics, 62(3), 1998, pp. 653-658
Authors:
EELES R
DUROCHER F
EDWARDS S
TEARE D
EASTON D
DEARNALEY D
SHEARER R
ARDERNJONES A
DOWE A
BADZIOCH M
AMOS C
LABRIE F
SIMARD J
NAROD S
FOULKES W
Citation: R. Eeles et al., DOES THE HEREDITARY PROSTATE-CANCER GENE, HPC1 CONTRIBUTE TO A LARGE PROPORTION OF FAMILIAL PROSTATE-CANCER - RESULTS FROM THE CRC BPG UK, TEXAN AND CANADIAN CONSORTIUM/, American journal of human genetics, 61(4), 1997, pp. 345-345
Authors:
FOSSA SD
STERNBERG C
SCHER HI
THEODORE CH
MEAD B
DEARNALEY D
ROBERTS JT
SKOVLUND E
Citation: Sd. Fossa et al., SURVIVAL OF PATIENTS WITH ADVANCED UROTHELIAL CANCER TREATED WITH CISPLATIN-BASED CHEMOTHERAPY, British Journal of Cancer, 74(10), 1996, pp. 1655-1659
Authors:
THOMAS R
DEARNALEY D
NICHOLLS J
NORMAN A
SAMPSON S
HORWICH A
Citation: R. Thomas et al., AN ANALYSIS OF SURVEILLANCE FOR STAGE-I COMBINED TERATOMA - SEMINOMA OF THE TESTIS, British Journal of Cancer, 74(1), 1996, pp. 59-62
Authors:
LEE M
WYNNE C
WEBB S
NAHUM AE
DEARNALEY D
Citation: M. Lee et al., A COMPARISON OF PROTON AND MEGAVOLTAGE X-RAY TREATMENT PLANNING FOR PROSTATE-CANCER, Radiotherapy and oncology, 33(3), 1994, pp. 239-253
Authors:
AAPRO M
PIGUET D
GIGER K
BAUER J
HAEFLIGER JM
BREMER K
CALS L
CATTAN A
CLAVEL M
CZYGAN P
DEARNALEY D
DIEHL V
HARJUNG M
HARPER P
ILLIGER H
KAYE S
KEIZER HJ
KERBRAT P
KONIG HJ
MONCUQUET P
DEBESANCON C
NAMER M
NOBEL A
NORTIER JWR
OBERLING F
PLAGNE R
REICHLE A
RIVIERE A
SOUKOP M
VEENHOF CHN
ZYLBERAIT D
HUNTER B
Citation: M. Aapro et al., THE ANTIEMETIC EFFICACY AND SAFETY OF GRANISETRON COMPARED WITH METOCLOPRAMIDE PLUS DEXAMETHASONE IN PATIENTS RECEIVING FRACTIONATED CHEMOTHERAPY OVER 5 DAYS, Journal of cancer research and clinical oncology, 119(9), 1993, pp. 555-559
Authors:
RATH U
UPADHYAYA BK
ARECHAVALA E
BOCKMANN H
DEARNALEY D
DROZ JP
FOSSA SD
HENRIKSSON R
AULITZKY WE
JONES WG
WEISSBACH L
PASKA W
FREEMAN A
Citation: U. Rath et al., ROLE OF ONDANSETRON PLUS DEXAMETHASONE IN FRACTIONATED CHEMOTHERAPY, Oncology, 50(3), 1993, pp. 168-172
Risultati:
1-12
|